FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366998177> ?p ?o ?g. }

• W4366998177 abstract "Glioblastoma (GBM) is an unmet clinical need characterized by a standard of care (SOC) 5-year survival rate of only 5%, and a treatment mostly palliative. Significant hurdles in GBM therapies include an effective penetration of therapeutics through the brain protective barrier, namely the blood-brain barrier (BBB), and a successful therapeutic delivery to brain-invading tumor cells post-BBB crossing. These hurdles, along with the poor prognosis and critical heterogeneity of the disease, have shifted attention to treatment modalities with capacity to precisely and sequentially target (i) BBB cells, inducing blood-to-brain transport, and (ii) GBM cells, leading to a higher therapeutic accumulation at the tumor site. This sequential targeting allows therapeutic molecules to reach the brain parenchyma and compromise molecular processes that support tumor cell invasion. Besides improving formulation and pharmacokinetics constraints of drugs, nanomedicines offer the possibility of being surface functionalized with multiple possibilities of targeting ligands, while delivering the desired therapeutic cargos to the biological sites of interest. Targeting ligands exploit the site-specific expression or overexpression of specific molecules on BBB and GBM cells, triggering brain plus tumor transport. Since the efficacy of single-ligand functionalized nanomedicines is limited due to the GBM anatomical site (brain) and disease complexity, this review presents an overview of multi-ligand functionalized, BBB and GBM sequentially- and dual-targeted nanomedicines reported in literature over the last 10 years. The role of the BBB in GBM progression, treatment options, and the multiple possibilities of currently available targeting ligands will be summarized. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease." @default.
• W4366998177 created "2023-04-27" @default.
• W4366998177 creator A5000767502 @default.
• W4366998177 creator A5041458969 @default.
• W4366998177 date "2023-04-25" @default.
• W4366998177 modified "2023-10-14" @default.
• W4366998177 title "Multi‐ligand functionalized blood‐to‐tumor sequential targeting strategies in the field of glioblastoma nanomedicine" @default.
• W4366998177 cites W1562680005 @default.
• W4366998177 cites W1951559178 @default.
• W4366998177 cites W1966022935 @default.
• W4366998177 cites W1966597723 @default.
• W4366998177 cites W1976947090 @default.
• W4366998177 cites W1978556565 @default.
• W4366998177 cites W1979900568 @default.
• W4366998177 cites W1981968613 @default.
• W4366998177 cites W1990689226 @default.
• W4366998177 cites W2000383291 @default.
• W4366998177 cites W2005464092 @default.
• W4366998177 cites W2012681969 @default.
• W4366998177 cites W2014509855 @default.
• W4366998177 cites W2023568521 @default.
• W4366998177 cites W2024787650 @default.
• W4366998177 cites W2024825549 @default.
• W4366998177 cites W2026402231 @default.
• W4366998177 cites W2035833975 @default.
• W4366998177 cites W2037571189 @default.
• W4366998177 cites W2038927253 @default.
• W4366998177 cites W2041187942 @default.
• W4366998177 cites W2041204432 @default.
• W4366998177 cites W2049515588 @default.
• W4366998177 cites W2051710488 @default.
• W4366998177 cites W2066912376 @default.
• W4366998177 cites W2070518196 @default.
• W4366998177 cites W2072610101 @default.
• W4366998177 cites W2073586533 @default.
• W4366998177 cites W2077128382 @default.
• W4366998177 cites W2077476931 @default.
• W4366998177 cites W2078308242 @default.
• W4366998177 cites W2078628247 @default.
• W4366998177 cites W2083053655 @default.
• W4366998177 cites W2083507370 @default.
• W4366998177 cites W2085178300 @default.
• W4366998177 cites W2086664688 @default.
• W4366998177 cites W2096287682 @default.
• W4366998177 cites W2101082342 @default.
• W4366998177 cites W2102866212 @default.
• W4366998177 cites W2108068107 @default.
• W4366998177 cites W2117133881 @default.
• W4366998177 cites W2117538553 @default.
• W4366998177 cites W2122684363 @default.
• W4366998177 cites W2135486162 @default.
• W4366998177 cites W2138800281 @default.
• W4366998177 cites W2154451644 @default.
• W4366998177 cites W2155680971 @default.
• W4366998177 cites W2159147379 @default.
• W4366998177 cites W2159464926 @default.
• W4366998177 cites W2164520862 @default.
• W4366998177 cites W2165734378 @default.
• W4366998177 cites W2167135384 @default.
• W4366998177 cites W2170726961 @default.
• W4366998177 cites W2171338310 @default.
• W4366998177 cites W2175727876 @default.
• W4366998177 cites W2180702805 @default.
• W4366998177 cites W2205491921 @default.
• W4366998177 cites W2208036228 @default.
• W4366998177 cites W2210939121 @default.
• W4366998177 cites W2220215167 @default.
• W4366998177 cites W2264385870 @default.
• W4366998177 cites W2316856761 @default.
• W4366998177 cites W2333056517 @default.
• W4366998177 cites W2344644350 @default.
• W4366998177 cites W2519985055 @default.
• W4366998177 cites W2523653731 @default.
• W4366998177 cites W2554773181 @default.
• W4366998177 cites W2579925017 @default.
• W4366998177 cites W2583036850 @default.
• W4366998177 cites W2594239688 @default.
• W4366998177 cites W2598922467 @default.
• W4366998177 cites W2612502936 @default.
• W4366998177 cites W2615804302 @default.
• W4366998177 cites W2741437013 @default.
• W4366998177 cites W2752314762 @default.
• W4366998177 cites W2768646562 @default.
• W4366998177 cites W2769408674 @default.
• W4366998177 cites W2770550238 @default.
• W4366998177 cites W2778283729 @default.
• W4366998177 cites W2779640537 @default.
• W4366998177 cites W2783105903 @default.
• W4366998177 cites W2790672246 @default.
• W4366998177 cites W2794838235 @default.
• W4366998177 cites W2800993426 @default.
• W4366998177 cites W2808836564 @default.
• W4366998177 cites W2830175972 @default.
• W4366998177 cites W2874770355 @default.
• W4366998177 cites W2883264688 @default.
• W4366998177 cites W2896144504 @default.
• W4366998177 cites W2896512274 @default.
• W4366998177 cites W2897844836 @default.
• W4366998177 cites W2899889509 @default.
• W4366998177 cites W2906335608 @default.

• next